Winton Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-366
Closed -$337K 1358
2026
Q1
$337K Sell
366
-12,989
-97% -$13.2M 0.01% 828
2025
Q4
$14.4M Buy
13,355
+10,655
+395% +$10.2M 0.5% 39
2025
Q3
$2.06M Buy
+2,700
New +$2.01M 0.08% 273
2025
Q2
Sell
-2,698
Closed -$2.23M 917
2025
Q1
$2.23M Sell
2,698
-1,550
-36% -$1.29M 0.14% 171
2024
Q4
$3.28M Buy
4,248
+3,892
+1,093% +$3.22M 0.22% 120
2024
Q3
$315K Sell
356
-3,045
-90% -$2.74M 0.02% 503
2024
Q2
$3.08M Buy
+3,401
New +$2.72M 0.21% 96
2023
Q4
Sell
-5,604
Closed -$3.01M 808
2023
Q3
$3.01M Sell
5,604
-3,545
-39% -$1.83M 0.25% 76
2023
Q2
$4.29M Sell
9,149
-4,384
-32% -$1.84M 0.36% 53
2023
Q1
$4.65M Buy
13,533
+5,094
+60% +$1.72M 0.28% 51
2022
Q4
$3.09M Buy
+8,439
New +$2.99M 0.2% 103
2022
Q3
Sell
-5,913
Closed -$1.92M 1030
2022
Q2
$1.92M Sell
5,913
-3,936
-40% -$1.18M 0.1% 277
2022
Q1
$2.82M Buy
9,849
+2,682
+37% +$690K 0.15% 157
2021
Q4
$1.98M Buy
7,167
+2,429
+51% +$616K 0.12% 229
2021
Q3
$1.09M Buy
+4,738
New +$1.17M 0.06% 456
2021
Q2
Sell
-3,723
Closed -$696K 1469
2021
Q1
$696K Buy
+3,723
New +$728K 0.04% 687
2020
Q3
Sell
-1,280
Closed -$210K 1546
2020
Q2
$210K Buy
+1,280
New +$196K 0.01% 1351
2019
Q3
Sell
-5,191
Closed -$575K 1615
2019
Q2
$575K Sell
5,191
-437
-8% -$51.5K 0.01% 616
2019
Q1
$730K Sell
5,628
-46,247
-89% -$5.62M 0.01% 441
2018
Q4
$6M Buy
+51,875
New +$5.79M 0.13% 254
2018
Q3
Sell
-3,276
Closed -$280K 1082
2018
Q2
$280K Sell
3,276
-4,505
-58% -$370K 0.01% 857
2018
Q1
$602K Buy
7,781
+978
+14% +$78.7K 0.02% 690
2017
Q4
$575K Sell
6,803
-5,832
-46% -$496K 0.02% 461
2017
Q3
$1.08M Sell
12,635
-122
-1% -$10K 0.03% 401
2017
Q2
$1.05M Buy
+12,757
New +$1.04M 0.03% 343
2016
Q4
Sell
-4,026
Closed -$323K 473
2016
Q3
$323K Sell
4,026
-166,224
-98% -$13.3M 0.01% 364
2016
Q2
$13.4M Sell
170,250
-73,198
-30% -$5.51M 0.22% 162
2016
Q1
$17.5M Buy
243,448
+89,637
+58% +$6.78M 0.19% 190
2015
Q4
$13M Sell
153,811
-111,859
-42% -$9.28M 0.12% 228
2015
Q3
$22.2M Buy
265,670
+18,731
+8% +$1.58M 0.18% 219
2015
Q2
$20.6M Sell
246,939
-217,472
-47% -$16.6M 0.19% 193
2015
Q1
$33.7M Buy
464,411
+86,134
+23% +$6.13M 0.27% 153
2014
Q4
$26.1M Sell
378,277
-602,334
-61% -$40.7M 0.32% 112
2014
Q3
$63.6M Sell
980,611
-253,014
-21% -$16M 0.45% 53
2014
Q2
$76.7M Buy
+1,233,625
New +$73.6M 0.52% 30

Other funds holding LLY

Winton Group's LLY Position: Q2 2026 in Review

Winton Group sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 366 shares — an estimated $337K sold.

Winton Group first reported a position in LLY in Q2 2014 and held it in 35 quarters. The position peaked at $76.7M in Q2 2014. 3,468 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Winton Group reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Winton Group sold 366 Eli Lilly shares in Q2 2026, an estimated $337K.
  • Winton Group first reported a position in Eli Lilly in Q2 2014 and held it in 35 quarters.
  • Winton Group's Eli Lilly position peaked at $76.7M in Q2 2014.
  • 3,468 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.